Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarah J Pickersgill"'
Publikováno v:
The Lancet Global Health, Vol 10, Iss 7, Pp e949-e950 (2022)
Externí odkaz:
https://doaj.org/article/e6d9361e459b4336b6e1de18449a8e71
Autor:
David A Watkins, MD, Jinyuan Qi, MA, Yoshito Kawakatsu, MPH, Sarah J Pickersgill, BSc, Susan E Horton, ProfPhD, Dean T Jamison, ProfPhD
Publikováno v:
The Lancet Global Health, Vol 8, Iss 6, Pp e829-e839 (2020)
Summary: Background: Disease Control Priorities, 3rd edition (DCP3), published two model health benefits packages (HBPs). This study estimates the overall costs and individual component costs of these packages in low-income countries (LICs) and lower
Externí odkaz:
https://doaj.org/article/9e07a7bb680a440abf9959fffcf7630f
Autor:
Sarah J. Pickersgill, William T. Msemburi, Laura Cobb, Nicole Ide, Andrew E. Moran, Yanfang Su, Xinpeng Xu, David A. Watkins
Publikováno v:
Nature Medicine. 28:1693-1699
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population blood pressure control in the context of a proposed 80-80-80 target: 80%
Autor:
Andrew E. Moran, Margaret Farrell, Danielle Cazabon, Swagata Kumar Sahoo, Doris Mugrditchian, Anirudh Pidugu, Carlos Chivardi, Magdalena Walbaum, Senait Alemayehu, Wanrudee Isaranuwatchai, Chaisiri Ankurawaranon, Sohel R. Choudhury, Sarah J. Pickersgill, David A. Watkins, Muhammad Jami Husain, Krishna D. Rao, Kunihiro Matsushita, Matti Marklund, Brian Hutchinson, Rachel Nugent, Deliana Kostova, Renu Garg
Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of pub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d37e678c350f4831f67e5f431a8c23
http://eprints.lse.ac.uk/117509/
http://eprints.lse.ac.uk/117509/
Autor:
David A Watkins, William T Msemburi, Sarah J Pickersgill, Yoshito Kawakatsu, Adrian Gheorghe, Katie Dain, Kjell Arne Johansson, Sanaa Said, Nina Renshaw, Mieraf T Tolla, Pakwanja D Twea, Cherian Varghese, Kalipso Chalkidou, Majid Ezzati, Ole Frithjof Norheim
Publikováno v:
Lancet (London, England). 399(10331)
Most countries have made little progress in achieving the Sustainable Development Goal (SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable diseases (NCDs) by a third from 2015 to 2030. In this Health Policy pape
Autor:
Dean T. Jamison, Sarah J Pickersgill, Susan Horton, David A Watkins, Jinyuan Qi, Yoshito Kawakatsu
Publikováno v:
The Lancet. Global Health
The Lancet Global Health, Vol 8, Iss 6, Pp e829-e839 (2020)
The Lancet Global Health, Vol 8, Iss 6, Pp e829-e839 (2020)
Summary: Background: Disease Control Priorities, 3rd edition (DCP3), published two model health benefits packages (HBPs). This study estimates the overall costs and individual component costs of these packages in low-income countries (LICs) and lower